1700012G19Rik Activators
1700012G19Rik Activators are a diverse array of chemical compounds that strategically enhance the activity of 1700012G19Rik through modulation of specific cellular signaling pathways. For instance, compounds like Forskolin and IBMX amplify the cAMP-PKA signaling axis, which can phosphorylate target proteins within the pathways that 1700012G19Rik is implicated in, thereby potentiating its function. Epigallocatechin gallate and Genistein, through their kinase inhibitory actions, may disinhibit pathways that 1700012G19Rik operates within, thus indirectly augmenting its activity. Similarly, PI3K inhibitors LY294002 and Wortmannin may enrich 1700012G19Rik's activity by attenuating the PI3K-AKT signaling route, providing an alternative signal flow through 1700012G19Rik-associated pathways.
Furthermore, PMA engages PKC, which might phosphorylate substrates and enhance 1700012G19Rik activity by stimulating relevant signaling networks. Thapsigargin and A23187, by altering intracellular calcium levels, may activate calcium-dependent signaling mechanisms that enhance 1700012G19Rik function. Compounds such as Sphingosine-1-phosphate also play a crucial role, as they may bolster 1700012G19Rik activity by participating in sphingolipid signaling pathways. Lastly, the MEK inhibitor U0126 and the p38 MAPK inhibitor SB203580 could potentially reconfigure intracellular signaling landscapes to favor the activation of pathways that involve 1700012G19Rik, thereby indirectly promoting its activity without affecting its expression levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a non-specific inhibitor of phosphodiesterases, thereby preventing the breakdown of cAMP and indirectly enhancing the activity of 1700012G19Rik through the same cAMP-dependent signaling pathways as Forskolin. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a kinase inhibitor that can influence the activity of 1700012G19Rik by inhibiting competitive signaling pathways, thereby indirectly enhancing the pathways 1700012G19Rik is involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can indirectly enhance the functional activity of 1700012G19Rik by altering downstream signaling pathways, particularly those involved in cell growth and survival, where 1700012G19Rik may play a role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, serves a similar function to LY294002, potentially enhancing the activity of 1700012G19Rik by shifting the balance of intracellular signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC which can lead to the activation of signaling cascades where 1700012G19Rik may be functionally active, thereby enhancing its activity indirectly. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels, which can enhance the activity of 1700012G19Rik if it is involved in calcium-dependent signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate can enhance the activity of 1700012G19Rik by modulating sphingolipid signaling pathways, which may cross-talk with pathways involving 1700012G19Rik. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could enhance the activity of 1700012G19Rik by reducing competitive signaling through tyrosine kinase pathways, potentially allowing for greater activity of 1700012G19Rik-related pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could enhance the activity of 1700012G19Rik by inhibiting a competing pathway, potentially upregulating the pathways where 1700012G19Rik is active. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, potentially enhancing the activity of 1700012G19Rik through calcium-dependent signaling mechanisms. | ||||||